BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan LP, Tan GW, Sivanesan VM, Goh SL, Ng XJ, Lim CS, Kim WR, Mohidin TBBM, Mohd Dali NS, Ong SH, Wong CY, Sawali H, Yap YY, Hassan F, Pua KC, Koay CE, Ng CC, Khoo AS; Malaysian Nasopharyngeal Carcinoma Study Group. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma. Int J Cancer 2020;146:2336-47. [PMID: 31469434 DOI: 10.1002/ijc.32656] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhu QY, Zhao GX, Li Y, Talakatta G, Mai HQ, Le QT, Young LS, Zeng MS. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma. MedComm (2020) 2021;2:175-206. [PMID: 34766141 DOI: 10.1002/mco2.32] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bao LH, Ji K, Li D, Liu SS, Song ZY, Xia GH. The biological function and diagnostic value of miR-762 in nasopharyngeal carcinoma. J Chin Med Assoc 2021;84:498-503. [PMID: 33742996 DOI: 10.1097/JCMA.0000000000000523] [Reference Citation Analysis]
3 Xu Y, Huang X, Ye W, Zhang Y, Li C, Bai P, Lin Z, Chen C. Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis. Cancer Cell Int 2020;20:408. [PMID: 32863767 DOI: 10.1186/s12935-020-01507-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tian Y, Tang L, Yi P, Pan Q, Han Y, Shi Y, Rao S, Tan S, Xia L, Lin J, Oyang L, Tang Y, Liang J, Luo X, Liao Q, Wang H, Zhou Y. MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma. J Cancer 2020;11:3976-85. [PMID: 32328201 DOI: 10.7150/jca.42734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lu T, Guo Q, Lin K, Chen H, Chen Y, Xu Y, Lin C, Su Y, Chen Y, Chen M, Zheng Y, Ye Y, Lin S, Zong J, Pan J. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma. Cancer Sci 2020;111:1711-23. [PMID: 32155300 DOI: 10.1111/cas.14381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Du T, Jiang J, Chen Y, Zhang N, Chen G, Wang X, Long X, Feng X. MiR-138-1-3p alters the stemness and radiosensitivity of tumor cells by targeting CRIPTO and the JAK2/STAT3 pathway in nasopharyngeal carcinoma. Ann Transl Med 2021;9:485. [PMID: 33850882 DOI: 10.21037/atm-21-521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Siak PY, Khoo AS, Leong CO, Hoh BP, Cheah SC. Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma. Cancers (Basel) 2021;13:3490. [PMID: 34298701 DOI: 10.3390/cancers13143490] [Reference Citation Analysis]
8 Chen L, Li M, Xu T, Qiu X, Chen C. Prognostic value of neutrophils for patients with nasopharyngeal carcinoma. Laryngoscope Investig Otolaryngol 2021;6:219-25. [PMID: 33869754 DOI: 10.1002/lio2.548] [Reference Citation Analysis]
9 Zhang J, Luo X, Huang Q, Huang Y. Clinicopathological and prognostic features of nasopharyngeal carcinoma in children and adolescents: A retrospective study of 196 cases in South China. Int J Cancer 2021;148:1087-96. [PMID: 32930415 DOI: 10.1002/ijc.33293] [Reference Citation Analysis]
10 Notarte KI, Senanayake S, Macaranas I, Albano PM, Mundo L, Fennell E, Leoncini L, Murray P. MicroRNA and Other Non-Coding RNAs in Epstein-Barr Virus-Associated Cancers. Cancers (Basel) 2021;13:3909. [PMID: 34359809 DOI: 10.3390/cancers13153909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Liu F, Wei J, Hao Y, Lan J, Li W, Weng J, Li M, Su C, Li B, Mo M, Tang F, Wang Y, Yang Y, Jiao W, Qu S. Long intergenic non-protein coding RNA 02570 promotes nasopharyngeal carcinoma progression by adsorbing microRNA miR-4649-3p thereby upregulating both sterol regulatory element binding protein 1, and fatty acid synthase. Bioengineered 2021;12:7119-30. [PMID: 34546840 DOI: 10.1080/21655979.2021.1979317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rao D, Fu M, Chen Y, Liu Q, Xiao L, Zhang X, Li Z, Li H, He Y, Chen Y, Chen J, Hu J, Huang Y. A combination of two ELISA tests for nasopharyngeal carcinoma screening in endemic areas based on a case-control study. PeerJ 2020;8:e10254. [PMID: 33240616 DOI: 10.7717/peerj.10254] [Reference Citation Analysis]
13 Ye Q, Guo J, Chen Y, Cui Z, Chen Y. Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:5793-802. [PMID: 34321926 DOI: 10.2147/CMAR.S320541] [Reference Citation Analysis]
14 Sun XS, Xie SY, Luo DH, Liu LT, Guo SS, Liu SL, Tang LQ, Chen QY, Mai HQ. Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016. Radiother Oncol 2021;162:7-17. [PMID: 34182012 DOI: 10.1016/j.radonc.2021.06.029] [Reference Citation Analysis]
15 Guan S, Wei J, Huang L, Wu L. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma. Eur J Med Chem 2020;207:112758. [PMID: 32858472 DOI: 10.1016/j.ejmech.2020.112758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, Savage PA, Lingen MW, Agrawal N, Izumchenko E. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer 2021. [PMID: 34876674 DOI: 10.1038/s41416-021-01626-0] [Reference Citation Analysis]
17 Trevisiol C, Gion M, Vaona A, Fabricio ASC, Roca E, Licitra L, Alfieri S, Bossi P. The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation. Oral Oncol 2021;114:105128. [PMID: 33444925 DOI: 10.1016/j.oraloncology.2020.105128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wardana T, Gunawan L, Herawati C, Oktriani R, Anwar S, Astuti I, Aryandono T, Mubarika S. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma. Asian Pac J Cancer Prev 2020;21:2777-82. [PMID: 32986380 DOI: 10.31557/APJCP.2020.21.9.2777] [Reference Citation Analysis]